NCT02918188View on ClinicalTrials.gov

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD

PHASE2RecruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2031

Conditions
Chronic Graft-versus-host Disease
Interventions
DRUG

Hydrogen

Patients will receive hydrogen-rich water orally (500mL three times one day, 0.6mM)

Trial Locations (1)

100048

RECRUITING

Navy General Hospital, Beijing

All Listed Sponsors
lead

Navy General Hospital, Beijing

OTHER

NCT02918188 - Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD | Biotech Hunter | Biotech Hunter